AbbVie layoffs, on the record
Every job cut, severance charge and restructuring AbbVie reported in its annual reports, 2023 to 2025, quoted from the filings.
Job cuts, severance and restructuring
None of AbbVie’s annual reports for 2023 to 2025 describes a layoff, workforce reduction or restructuring.
| Fiscal year ended | Restructuring charges |
|---|---|
| 2016-12-31 | $52 million |
| 2017-12-31 | $86 million |
| 2018-12-31 | $59 million |
| 2019-12-31 | $219 million |
AbbVie has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from AbbVie’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.